Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
NVIDIA
NVDA
Adobe
ADBE
US Stock MarketDetailed Quotes
CFRXQ ContraFect Corporation
- 0.000
- 0.0000.00%
15min DelayClose Dec 26 16:00 ET
10.70Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)10.70MShares0.14052wk High0.00P/B9.57Float Cap0.00052wk Low--Dividend TTM9.57MShs Float4992.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About ContraFect Corporation Company
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Company Profile
SymbolCFRXQ
Company NameContraFect Corporation
Listing DateJul 29, 2014
Founded2008
CEODr. Roger J. Pomerantz, F.A.C.P.,M.D.
MarketPink Market
Employees23
Fiscal Year Ends12-31
Address28 Wells Avenue,3rd Floor
CityYonkers
ProvinceNew York
CountryUnited States of America
Zip Code10701
Phone1-914-207-2300
Websitehttp://www.contrafect.com
Company Executives
- Name
- Position
- Salary
- Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.23M
- Michael Messinger, C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 414.07B
- Dr. Steven C. Gilman, PhD
- Vice Chairman of the Board
- 160.54K
- Dr. Sol J. Barer,PhD
- Lead Independent Director
- 176.04K
- Dr. Michael J. Otto,PhD
- Independent Director
- 160.04K
- Dr. Jane F. Barlow, M.B.A.,M.D.,M.P.H.
- Independent Director
- 155.54K
- David N. Low, Jr
- Independent Director
- 165.04K
- Cary W. Sucoff, J.D.
- Independent Director
- 155.54K
- Dr. Lishan Aklog, M.D.
- Independent Director
- 150.54K
- Natalie Bogdanos, J.D.
- General Counsel and Corporate Secretary
- 844.90K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.